OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Synergistic Antiviral Activity of Pamapimod and Pioglitazone against SARS-CoV-2 and Its Variants of Concern
Christian Setz, Maximilian Große, Janina Auth, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 12, pp. 6830-6830
Open Access | Times Cited: 8

Showing 8 citing articles:

Review of COVID-19 Therapeutics by Mechanism: From Discovery to Approval
Hee Sun Choi, A Young Choi, Jeffrey B. Kopp, et al.
Journal of Korean Medical Science (2024) Vol. 39, Iss. 14
Open Access | Times Cited: 6

Repurposing clinically available drugs and therapies for pathogenic targets to combat SARS‐CoV‐2
Yiying Xue, Husheng Mei, Yisa Chen, et al.
MedComm (2023) Vol. 4, Iss. 3
Open Access | Times Cited: 11

Viral infection and host immune response in diabetes
Garima Joshi, Anushka Das, Garima Verma, et al.
IUBMB Life (2023) Vol. 76, Iss. 5, pp. 242-266
Closed Access | Times Cited: 7

European Black Elderberry Fruit Extract Inhibits Replication of SARS-CoV-2 In Vitro
Christian Setz, Maria Fröba, Maximilian Große, et al.
Nutraceuticals (2023) Vol. 3, Iss. 1, pp. 91-106
Open Access | Times Cited: 5

Evaluation of Potential Furin Protease Inhibitory Properties of Pioglitazone, Rosiglitazone, and Pirfenidone: An In Silico Docking and Molecular Dynamics Simulation Approach
Ahtziri Socorro Carranza-Aranda, Carlos Daniel Díaz-Palomera, Eduardo Lepe-Reynoso, et al.
Current Issues in Molecular Biology (2024) Vol. 46, Iss. 8, pp. 8665-8684
Open Access | Times Cited: 1

Effect of pioglitazone on inflammatory response and clinical outcome in T2DM patients with COVID-19: a randomized multicenter double-blind clinical trial
Khaled Baagar, Thamer Alessa, Mohamed Abu‐Farha, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 1

Antivirals and Vaccines
Nuno Taveira
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 12, pp. 10315-10315
Open Access

The KINETIC phase 2 randomized controlled trial of oral pamapimod-pioglitazone in non-critically ill COVID-19 inpatients
Thierry Fumeaux, C Berger, Andreas R. Bausch, et al.
iScience (2023) Vol. 26, Iss. 10, pp. 108038-108038
Open Access

Page 1

Scroll to top